Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer
We analyzed transcriptional changes in 4 prostate cancer cell lines following treatment with the BET inhibitor I-BET762 using Affymetrix Human Genome U133 Plus 2.0 Arrays.
Cancer Type: Prostate Cancer
GPL: 570
Number of Genes with Data: 978
Number Observations: 24
Number Outputs: 2
Imbalanced Ratio: 1
Default Task: Classification